Vasiyani H, Wadhwa B. STING activation and overcoming the challenges associated with STING agonists using ADC (antibody-drug conjugate) and other delivery systems. Cell Signal. 2025 Apr;128:111647.
- DOI:
http://dx.doi.org/10.1016/j.cellsig.2025.111647
Gruber DR, Cummins EJ, et al. Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models. Mol Cancer Ther. 2025 Oct 29.
- DOI:
http://dx.doi.org/10.1158/1535-7163.MCT-25-0108